This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Neurogenetics  • Stroke  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Barbara Voetsch, MD, PhD; Kelly S. Benke, AB; Carolien I. Panhuysen, MD, PhD; Benito P. Damasceno, MD, PhD; Joseph Loscalzo, MD, PhD

Arch Neurol. 2004;61:351-356.

Background  Serum paraoxonase (PON1) is a high-density lipoprotein–associated esterase with antioxidant and antiatherogenic properties that has recently been implicated in the pathogenesis of cardiovascular disease. Interindividual variability in PON1 levels is determined by the Q192R and L55M coding region polymorphisms and by 2 recently described polymorphisms in the promoter of the PON1 gene, C(-107)T and G(–824)A.

Objective  To determine the association of the PON1 promoter polymorphisms with arterial ischemic stroke (AIS) in the young.

Design, Setting, and Patients  We studied 118 young patients (age, <45 years) with a first nonfatal AIS of undetermined etiology and 118 control subjects, matched simultaneously for age and sex. The PON1 C(-107)T polymorphism was determined by single-stranded conformational polymorphism analysis and the G(-824)A substitution by polymerase chain reaction and restriction enzyme digestion.

Results  The presence of the low-expressor -107T allele was associated with an independent increase in overall risk of AIS (odds ratio [OR], 2.69; 95% confidence interval [CI], 1.06-6.78; P = .04) by conditional multiple logistic regression analysis. Among individuals with the 192RR genotype, the presence of the -107T allele led to a higher but nonsignificant risk, yielding an OR of 4.15 (95% CI, 0.35-48.76; P = .15) when compared with noncarriers of the T allele and 17.01 (95% CI, 1.74-166.35; P = .02) when compared with noncarriers of either variant. No significant difference between groups was found regarding the G(-824)A polymorphism.

Conclusion  These findings suggest that the PON1 -107T allele is independently associated with the risk of AIS, in addition to interacting with and potentiating the risk conferred by the Q192R polymorphism.

From the Whitaker Cardiovascular Institute (Drs Voetsch and Loscalzo) and the Genetics Program (Ms Benke and Dr Panhuysen), Evans Department of Medicine, Boston University School of Medicine, Boston, Mass; and the Department of Neurology, State University of Campinas, Campinas, São Paulo, Brazil (Drs Voetsch and Damasceno).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease
Carlson et al.
J. Lipid Res. 2006;47:1014-1024.
ABSTRACT | FULL TEXT  

Polymorphisms in the PON gene cluster are associated with Alzheimer disease
Erlich et al.
Hum Mol Genet 2006;15:77-85.
ABSTRACT | FULL TEXT  

Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke
Ranade et al.
Stroke 2005;36:2346-2350.
ABSTRACT | FULL TEXT  

Update on the Genetics of Stroke and Cerebrovascular Disease 2004
Alberts and Tournier-Lasserve
Stroke 2005;36:179-181.
FULL TEXT